AxoGen (AXGN) EBITDA US GAAP (year values)

FY2021 FY2022 FY2023 FY2024 FY2025   LTM ?
EBITDA, bln rub ? -20.9 -23.5 -13.3 6.08 0.192   5.69
Changes by years, y/y, % +8% +12% -43% -146% -97%    

AxoGen. EBITDA US GAAP, bln rub

AxoGen. EBITDA US GAAP, changes, %

AxoGen. EBITDA US GAAP, sum by quarters, bln rub

AxoGen (AXGN) EBITDA US GAAP (quarter values)

FY2025Q2 FY2025Q3 FY2025Q4 FY2026Q1 FY2026Q2   LTM ?
EBITDA, bln rub ? 4.38 12.6 -8.50 -16.8 -2.16   5.69
Changes by years, y/y, % +88% +532% -304% -5 726% -149%    
Changes by quarters, q/q, % +1 368% +189% -167% +97% -87%    

AxoGen. EBITDA US GAAP, bln rub

AxoGen. EBITDA US GAAP, changes, y/y, %

AxoGen. EBITDA US GAAP, changes, q/q, %